Canadian Federal Government Business Commissioner and the Canadian Business Representative in South China visited Tekwon. The management team introduced the company's product technology and development strategy to the guests. Tekwon expressed much appreciation for the long-time support and superior service by Canada's Federal Government Trade Representative Office in China.
The main R&D team of Tekwon is from the pharmaceutical industry in North America. After a market expansion in Asia Pacific area, Tekwon settled in China after a great recommendation by the Xiamen Municipal Office of Overseas Chinese Affairs and Haicang District Government. The Tekwon factory is located in Xiamen Biomedical Industrial Park.
All production lines are built in leading technologies in accordance with American GMP standards, specifically to research and development and production of new peptide biopharmaceutical products.
The company is planning to increase investment in China in order to speed up the industrial layout and lead the comprehensive upgrading of pharmaceutical peptide products technology and industry in China.